This downturn is different.
Youssef Sebban interview by Carol Massar and Tim Stenovec on Bloomberg Businessweek.
AGELESS THERAPEUTICS
Improving protein therapeutics through anti-glycation modification.
Insight Category: Podcasts
Menu
